Pain in irritable bowel syndrome: Does anything really help?-Reference-Cited by-同舟云学术

Pain in irritable bowel syndrome: Does anything really help?

Published:2021-12-03 Issue:1 Volume:34 Page:
ISSN:1350-1925
Container-title:Neurogastroenterology & Motility
language:en
Short-container-title:Neurogastroenterology Motil

Author:

BouSaba Joelle¹,Sannaa Wassel¹,Camilleri Michael¹^ORCID

Affiliation:

1. Division of Gastroenterology and Hepatology Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER) Mayo Clinic Rochester Minnesota USA

Publisher

Wiley

Subject

Gastroenterology,Endocrine and Autonomic Systems,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/nmo.14305

Reference54 articles.

1. Oral and parenteral anti‐neuropathic agents for the management of pain and discomfort in irritable bowel syndrome: a systematic review and meta‐analysis;Lambarth A;Neurogastroenterol Motil,2021

2. Efficacy of soluble fibre, antispasmodic drugs, and gut–brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis

3. Diagnosis and Treatment of Irritable Bowel Syndrome

4. Dietary and pharmacological treatment of abdominal pain in IBS

5. Constipation

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential roles of serotonin receptor subtypes in regulation of neurotrophin receptor expression and intestinal hypernociception;HISTOL HISTOPATHOL;2024

2. Intracerebroventricular administration of TRH Agonist, RX-77368 alleviates visceral pain induced by colorectal distension in rats;Peptides;2024-05

3. Altered gut microbial functional pathways in people with Irritable Bowel Syndrome enable precision health insights;2024-02-16

4. Specific probiotics and prebiotics to improve the quality of life of patients with chronic irritable bowel syndrome;Minerva Gastroenterology;2024-01

5. Efficacy and safety of olorinab, a full agonist of the cannabinoid receptor 2, for the treatment of abdominal pain in patients with irritable bowel syndrome: Results from a phase 2b randomized placebo‐controlled trial (CAPTIVATE);Neurogastroenterology & Motility;2023-02-05